Myriad Genetics, Inc. (MYGN) Social Stream



Myriad Genetics, Inc. (MYGN): $23.32

0.16 (+0.69%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

MYRIAD GENETICS INC (MYGN) Price Targets From Analysts

Use the tables below to see what analysts covering MYRIAD GENETICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 6 $35 $26 $30.6 $18.08 69.25%
2022-02-25 6 $33 $26 $29.4 $18.08 62.61%
2022-02-28 6 $32 $24 $28.4 $18.08 57.08%
2022-03-03 6 $30 $26 $28 $18.08 54.87%
2022-04-04 6 $30 $24.001 $27.2 $18.08 50.44%
2022-04-20 6 $29 $24.001 $26.8 $18.08 48.23%
2022-05-06 6 $29 $24.001 $26.6 $18.08 47.12%
2022-05-09 6 $27 $20 $24.2 $18.08 33.85%
2022-06-03 6 $27 $20 $23.2 $18.08 28.32%
2022-07-15 6 $26 $20 $22.8 $18.08 26.11%
2022-08-13 6 $32 $20 $25.6 $18.08 41.59%
2022-09-17 6 $32 $20 $26.4 $18.08 46.02%
2022-10-06 7 $32 $20 $25.666 $18.08 41.96%
2022-10-17 6 $32 $20 $25.666 $18.08 41.96%
2022-11-01 6 $32 $20 $25.166 $18.08 39.19%
2022-11-02 7 $27 $20 $23.833 $18.08 31.82%
2022-11-03 7 $25 $18 $21.166 $18.08 17.07%
2022-12-12 7 $25 $18 $20.833 $18.08 15.23%
2023-01-06 7 $25 $18 $20.166 $18.08 11.54%
2023-01-26 7 $25 $18 $20.857 $18.08 15.36%
2023-03-01 7 $25 $17 $20.428 $18.08 12.99%
2023-03-03 7 $27 $17 $20.857 $18.08 15.36%
2023-03-06 7 $27 $18 $21.857 $18.08 20.89%
2023-04-03 7 $27 $18 $22 $18.08 21.68%
2023-04-18 7 $27 $18 $22.428 $18.08 24.05%
2023-04-21 7 $30 $18 $23.142 $18.08 28%
2023-05-05 8 $30 $18 $23 $18.08 27.21%
2023-06-06 8 $30 $18 $23.875 $18.08 32.05%
2023-07-05 8 $30 $18.001 $23.5 $18.08 29.98%
2023-07-24 8 $30 $18.001 $23.875 $18.08 32.05%
2023-08-03 8 $30 $18.001 $24.25 $18.08 34.13%
2023-08-04 8 $28 $18.001 $23.687 $18.08 31.01%
2023-08-08 8 $28 $17 $23.312 $18.08 28.94%
2023-09-20 8 $28 $17 $22.937 $18.08 26.86%
2023-10-18 8 $28 $17 $22.187 $18.08 22.72%
2023-11-07 8 $28 $17 $21.812 $18.08 20.64%
2023-11-08 8 $28 $14 $21.687 $18.08 19.95%
2023-12-01 8 $28 $14 $21.437 $18.08 18.57%
2023-12-20 9 $28 $14 $21.611 $18.08 19.53%

The Trend in the Analyst Price Target


MYGN's average price target has moved up $1.02 over the prior 45 weeks.

MYGN reports an average of 11.59% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-01 7 25 17 20.428 21.42 -4.63%
2023-09-20 8 28 17 22.937 17.00 34.92%
2023-10-18 8 28 17 22.187 15.06 47.32%
2023-11-07 8 28 17 21.812 17.76 22.82%
2023-11-08 8 28 14 21.687 17.89 21.22%

MYGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 1 5 1 1 9

The Trend in the Broker Recommendations


Over the past 35 weeks, MYGN's average broker recommendation rating improved by 0.29.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MYGN as an investment opportunity.

  • In terms of how MYRIAD GENETICS INC fares relative to all US stocks, note that its average analyst price target is greater than 1277.25% of that group.
  • In terms of how MYRIAD GENETICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1005.15% of that group.
  • In the context of Pharmaceutical Products stocks, MYRIAD GENETICS INC's upside potential (average analyst target price relative to current price) is greater than 1251.09% of them.
  • MYRIAD GENETICS INC's number of analysts covering the stock is greater than 1841.51% of stocks in the mid market cap category.

Stocks similar to MYRIAD GENETICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEOG, EVO, and MOR.

Is MYGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!